EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic

Detalles Bibliográficos
Autores principales: Tebaibia, A, Mammeri, A, Brahimi, H, Ammi, M, AitSaid, N, Lebdjiri, M, Grine, S, Tagzout, D, Hadjene, L, Bradaia, H, Hamrour, F, Hocine, O, Hamouni, M, Toudji, N, Aouadi, M, Khedairia, I, Djafour, W, Bouriah, A, Belkadi, A, Bouabana, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232749/
http://dx.doi.org/10.1016/j.jval.2022.04.756
_version_ 1784735661737115648
author Tebaibia, A
Mammeri, A
Brahimi, H
Ammi, M
AitSaid, N
Lebdjiri, M
Grine, S
Tagzout, D
Hadjene, L
Bradaia, H
Hamrour, F
Hocine, O
Hamouni, M
Toudji, N
Aouadi, M
Khedairia, I
Djafour, W
Bouriah, A
Belkadi, A
Bouabana, F
author_facet Tebaibia, A
Mammeri, A
Brahimi, H
Ammi, M
AitSaid, N
Lebdjiri, M
Grine, S
Tagzout, D
Hadjene, L
Bradaia, H
Hamrour, F
Hocine, O
Hamouni, M
Toudji, N
Aouadi, M
Khedairia, I
Djafour, W
Bouriah, A
Belkadi, A
Bouabana, F
author_sort Tebaibia, A
collection PubMed
description
format Online
Article
Text
id pubmed-9232749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92327492022-06-27 EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic Tebaibia, A Mammeri, A Brahimi, H Ammi, M AitSaid, N Lebdjiri, M Grine, S Tagzout, D Hadjene, L Bradaia, H Hamrour, F Hocine, O Hamouni, M Toudji, N Aouadi, M Khedairia, I Djafour, W Bouriah, A Belkadi, A Bouabana, F Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232749/ http://dx.doi.org/10.1016/j.jval.2022.04.756 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tebaibia, A
Mammeri, A
Brahimi, H
Ammi, M
AitSaid, N
Lebdjiri, M
Grine, S
Tagzout, D
Hadjene, L
Bradaia, H
Hamrour, F
Hocine, O
Hamouni, M
Toudji, N
Aouadi, M
Khedairia, I
Djafour, W
Bouriah, A
Belkadi, A
Bouabana, F
EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title_full EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title_fullStr EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title_full_unstemmed EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title_short EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic
title_sort eph3 diabetes and the covid-19 epidemic in algeria: prevalence and characteristics of patients diagnosed during the first 6 months of the epidemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232749/
http://dx.doi.org/10.1016/j.jval.2022.04.756
work_keys_str_mv AT tebaibiaa eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT mammeria eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT brahimih eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT ammim eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT aitsaidn eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT lebdjirim eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT grines eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT tagzoutd eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT hadjenel eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT bradaiah eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT hamrourf eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT hocineo eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT hamounim eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT toudjin eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT aouadim eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT khedairiai eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT djafourw eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT bouriaha eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT belkadia eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic
AT bouabanaf eph3diabetesandthecovid19epidemicinalgeriaprevalenceandcharacteristicsofpatientsdiagnosedduringthefirst6monthsoftheepidemic

Ejemplares similares